Skip to Content
Merck
  • Dose proportionality study of loperamide following oral administration of loperamide oxide.

Dose proportionality study of loperamide following oral administration of loperamide oxide.

European journal of clinical pharmacology (1992-01-01)
F Kamali, L Adriaens, M L Huang, R Woestenborghs, M Emanuel, M D Rawlins
ABSTRACT

The pharmacokinetics of loperamide, after oral administration of increasing doses (1 to 16 mg) of loperamide oxide, has been investigated in 10 healthy male volunteers, using a randomised cross-over design. Comparison of the maximum plasma loperamide concentration and AUC demonstrated that the bioavailability of loperamide was proportional to the dose of loperamide oxide administered.

MATERIALS
Product Number
Brand
Product Description

Loperamide oxide monohydrate, European Pharmacopoeia (EP) Reference Standard